SciELO - Scientific Electronic Library Online

 
vol.55 issue9The role of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 in diabetic nephropathyTreatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos Brasileiros de Endocrinologia & Metabologia

Print version ISSN 0004-2730

Abstract

BORGES, Anna Paula de Sá; GUIDONI, Camilo Molino; FREITAS, Osvaldo de  and  PEREIRA, Leonardo Régis Leira. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq Bras Endocrinol Metab [online]. 2011, vol.55, n.9, pp. 686-691. ISSN 0004-2730.  http://dx.doi.org/10.1590/S0004-27302011000900003.

OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.

Keywords : Unified Healthcare System; diabetes mellitus; healthcare costs; pharmaceutical care; pharmacoeconomics.

        · abstract in Portuguese     · text in English     · pdf in English